PDB Short entry for 1LC9 HEADER CELL CYCLE 06-APR-02 1LC9 TITLE THEORETICAL STRUCTURE OF HUMAN CYCLIN-DEPENDENT KINASE 1 TITLE 2 (CDK1) COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYCLIN-DEPENDENT KINASE 1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CDK1, CELL DIVISION CONTROL PROTEIN 2 HOMOLOG; COMPND 5 EC: 2.7.1.- SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 CELLULAR_LOCATION: NUCLEUS KEYWDS TRANSFERASE, SERINE/THREONINE-PROTEIN KINASE, ATP-BINDING, KEYWDS 2 CELL CYCLE, CELL DIVISION, MITOSIS, NUCLEAR PROTEIN, KEYWDS 3 PHOSPHORYLATION, POLYMORPHISM. EXPDTA THEORETICAL MODEL AUTHOR K.NARAYANA,R.P.K.SURENDRA,J.A.R.P.SARMA REVDAT 1 17-APR-02 1LC9 0 JRNL AUTH K.NARAYANA,R.P.K.SURENDRA,J.A.R.P.SARMA JRNL TITL THEORETICAL STRUCTURE OF HUMAN CYCLIN-DEPENDENT JRNL TITL 2 KINASE 1 (CDK1) JRNL REF TO BE PUBLISHED JRNL REFN REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.G.LEE,P.NURSE REMARK 1 TITL COMPLEMENTATION USED TO CLONE A HUMAN HOMOLOGUE OF REMARK 1 TITL 2 THE FISSION YEAST CELL CYCLE CONTROL GENE CDC2 REMARK 1 REF NATURE V. 327 31 1987 REMARK 1 REFN ASTM NATUAS UK ISSN 0028-0836 REMARK 1 REFERENCE 2 REMARK 1 AUTH T.OHTA,K.OKAMOTO,F.ISOHASHI,K.SHIBATA,M.FUKUDA, REMARK 1 AUTH 2 S.YAMAGUCHI,Y.XIONG REMARK 1 TITL T-LOOP DELETION OF CDC2 FROM BREAST CANCER TISSUES REMARK 1 TITL 2 ELIMINATES BINDING TO CYCLIN B1 AND REMARK 1 TITL 3 CYCLIN-DEPENDENT KINASE INHIBITOR P21 REMARK 1 REF CANCER RES. V. 58 1095 1998 REMARK 1 REFN ASTM CNREA8 US ISSN 0008-5472 REMARK 1 REFERENCE 3 REMARK 1 AUTH G.DRAETTA,D.BEACH REMARK 1 TITL ACTIVATION OF CDC2 PROTEIN KINASE DURING MITOSIS REMARK 1 TITL 2 IN HUMAN CELLS: CELL CYCLE-DEPENDENT REMARK 1 TITL 3 PHOSPHORYLATION AND SUBUNIT REARRANGEMENT REMARK 1 REF CELL (CAMBRIDGE,MASS.) V. 54 17 1988 REMARK 1 REFN ASTM CELLB5 US ISSN 0092-8674 REMARK 1 REFERENCE 4 REMARK 1 AUTH M.IKUTA,K.KAMATA,K.FUKASAWA,T.HONMA,T.MACHIDA, REMARK 1 AUTH 2 H.HIRAI,I.SUZUKI-TAKAHASHI,T.HAYAMA,S.NISHIMURA REMARK 1 TITL CRYSTALLOGRAPHIC APPROACH TO IDENTIFICATION OF REMARK 1 TITL 2 CYCLIN-DEPENDENT KINASE 4 (CDK4)-SPECIFIC REMARK 1 TITL 3 INHIBITORS BY USING CDK4 MIMIC CDK2 PROTEIN REMARK 1 REF J.BIOL.CHEM. V. 276 27548 2001 REMARK 1 REFN ASTM JBCHA3 US ISSN 0021-9258 REMARK 1 REFERENCE 5 REMARK 1 AUTH T.G.DAVIES,P.TUNNAH,L.MEIJER,D.MARKO,G.EISENBRAND, REMARK 1 AUTH 2 J.A.ENDICOTT,M.E.NOBLE REMARK 1 TITL INHIBITOR BINDING TO ACTIVE AND INACTIVE CDK2: THE REMARK 1 TITL 2 CRYSTAL STRUCTURE OF CDK2-CYCLIN REMARK 1 TITL 3 A/INDIRUBIN-5-SULPHONATE REMARK 1 REF STRUCTURE V. 9 389 2001 REMARK 1 REFN ASTM STRUE6 UK ISSN 0969-2126 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : NULL REMARK 3 AUTHORS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1LC9 COMPLIES WITH FORMAT V. 2.3, 09-JULY-1998 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-APR-2002. REMARK 100 THE RCSB ID CODE IS RCSB015834. REMARK 220 REMARK 220 EXPERIMENTAL DETAILS REMARK 220 EXPERIMENT TYPE : THEORETICAL MODELLING REMARK 220 REMARK 220 REMARK: COMPARATIVE MODELLING REMARK 225 REMARK 225 THEORETICAL MODEL REMARK 225 THE COORDINATES IN THIS ENTRY REPRESENT A MODEL STRUCTURE. REMARK 225 PROTEIN DATA BANK CONVENTIONS REQUIRE THAT CRYST1 AND REMARK 225 SCALE RECORDS BE INCLUDED, BUT THE VALUES ON THESE REMARK 225 RECORDS ARE MEANINGLESS. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES: ENGH AND HUBER, 1991 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 TYR A 169 CA - CB - CG ANGL. DEV. =-13.3 DEGREES REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 165 136.46 76.57 REMARK 500 ASN A 255 -36.66 128.62 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1GII RELATED DB: PDB REMARK 900 1GII CHAIN A HAS 65% SEQUENCE SIMILARITY (E-112) WITH CDK1 REMARK 900 RELATED ID: 1E9H RELATED DB: PDB REMARK 900 1E9H CHAIN A HAS 64% SEQUENCE SIMILARITY (E-111) WITH CDK1 DBREF 1LC9 A 1 297 UNP P06493 CDC2_HUMAN 1 297 SEQRES 1 A 297 MET GLU ASP TYR THR LYS ILE GLU LYS ILE GLY GLU GLY SEQRES 2 A 297 THR TYR GLY VAL VAL TYR LYS GLY ARG HIS LYS THR THR SEQRES 3 A 297 GLY GLN VAL VAL ALA MET LYS LYS ILE ARG LEU GLU SER SEQRES 4 A 297 GLU GLU GLU GLY VAL PRO SER THR ALA ILE ARG GLU ILE SEQRES 5 A 297 SER LEU LEU LYS GLU LEU ARG HIS PRO ASN ILE VAL SER SEQRES 6 A 297 LEU GLN ASP VAL LEU MET GLN ASP SER ARG LEU TYR LEU SEQRES 7 A 297 ILE PHE GLU PHE LEU SER MET ASP LEU LYS LYS TYR LEU SEQRES 8 A 297 ASP SER ILE PRO PRO GLY GLN TYR MET ASP SER SER LEU SEQRES 9 A 297 VAL LYS SER TYR LEU TYR GLN ILE LEU GLN GLY ILE VAL SEQRES 10 A 297 PHE CYS HIS SER ARG ARG VAL LEU HIS ARG ASP LEU LYS SEQRES 11 A 297 PRO GLN ASN LEU LEU ILE ASP ASP LYS GLY THR ILE LYS SEQRES 12 A 297 LEU ALA ASP PHE GLY LEU ALA ARG ALA PHE GLY ILE PRO SEQRES 13 A 297 ILE ARG VAL TYR THR HIS GLU VAL VAL THR LEU TRP TYR SEQRES 14 A 297 ARG SER PRO GLU VAL LEU LEU GLY SER ALA ARG TYR SER SEQRES 15 A 297 THR PRO VAL ASP ILE TRP SER ILE GLY THR ILE PHE ALA SEQRES 16 A 297 GLU LEU ALA THR LYS LYS PRO LEU PHE HIS GLY ASP SER SEQRES 17 A 297 GLU ILE ASP GLN LEU PHE ARG ILE PHE ARG ALA LEU GLY SEQRES 18 A 297 THR PRO ASN ASN GLU VAL TRP PRO GLU VAL GLU SER LEU SEQRES 19 A 297 GLN ASP TYR LYS ASN THR PHE PRO LYS TRP LYS PRO GLY SEQRES 20 A 297 SER LEU ALA SER HIS VAL LYS ASN LEU ASP GLU ASN GLY SEQRES 21 A 297 LEU ASP LEU LEU SER LYS MET LEU ILE TYR ASP PRO ALA SEQRES 22 A 297 LYS ARG ILE SER GLY LYS MET ALA LEU ASN HIS PRO TYR SEQRES 23 A 297 PHE ASN ASP LEU ASP ASN GLN ILE LYS LYS MET HELIX 1 1 PRO A 45 LEU A 58 1 14 HELIX 2 2 LEU A 87 ILE A 94 1 8 HELIX 3 3 ASP A 101 ARG A 122 1 22 HELIX 4 4 THR A 166 ARG A 170 5 5 HELIX 5 5 SER A 171 GLY A 177 1 7 HELIX 6 6 THR A 183 LYS A 200 1 18 HELIX 7 7 SER A 208 GLY A 221 1 14 HELIX 8 8 SER A 248 VAL A 253 1 6 HELIX 9 9 ASP A 257 LEU A 268 1 12 HELIX 10 10 SER A 277 HIS A 284 1 8 HELIX 11 11 PRO A 285 ASN A 288 5 4 SHEET 1 A 5 TYR A 4 GLU A 12 0 SHEET 2 A 5 VAL A 17 HIS A 23 -1 O LYS A 20 N GLU A 8 SHEET 3 A 5 VAL A 29 ARG A 36 -1 O VAL A 30 N GLY A 21 SHEET 4 A 5 ARG A 75 GLU A 81 -1 O LEU A 76 N ILE A 35 SHEET 5 A 5 LEU A 66 MET A 71 -1 N ASP A 68 O ILE A 79 SHEET 1 B 3 MET A 85 ASP A 86 0 SHEET 2 B 3 LEU A 134 ILE A 136 -1 O ILE A 136 N MET A 85 SHEET 3 B 3 ILE A 142 LEU A 144 -1 O LYS A 143 N LEU A 135 SHEET 1 C 2 VAL A 124 LEU A 125 0 SHEET 2 C 2 ARG A 151 ALA A 152 -1 O ARG A 151 N LEU A 125 CISPEP 1 ILE A 155 PRO A 156 0 -1.58 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000